Alnylam Pharmaceuticals ALNY
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$187.22M (2 inflow days, 18 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 49.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 3.57% to 4.08% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q4 | +3,968,086 | 8.0% |
| Capital Research | Mutual Fund | 2026/Q4 | +3,860,508 | 18.6% |
| Baillie Gifford | Mutual Fund | 2026/Q4 | +3,052,580 | 4.1% |
| Wellington Management Group | Mutual Fund | 2026/Q4 | +1,368,097 | 2.6% |
| AQR Capital Management | Hedge Fund | 2026/Q4 | +952,922 | 1.2% |
| Bank of America Corporation | Public Company | 2026/Q4 | +713,650 | 1.1% |
| Brown Advisory Incorporated | Mutual Fund | 2026/Q4 | +697,360 | 0.6% |
| Orbis Investment Management Limited | Mutual Fund | 2026/Q4 | +433,768 | 1.8% |
| Polar Capital Holdings Plc | Mutual Fund | 2026/Q4 | +271,046 | 0.6% |
| State Street Global Advisors | Mutual Fund | 2026/Q4 | +261,617 | 2.9% |
| Manulife Asset Management | Mutual Fund | 2026/Q4 | +257,935 | 0.9% |
| Bellevue Asset Management AG | Mutual Fund | 2026/Q4 | +239,230 | 0.2% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q4 | +236,438 | 0.3% |
| Holocene Advisors, LP | Hedge Fund | 2026/Q4 | +217,000 | 0.2% |
| Pictet Asset Management Limited | Mutual Fund | 2026/Q4 | +216,555 | 0.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | David E. Pyott | Independent Director | Derivative Exercise and Retained | +3,780 | $71.99 | 32,591 |
| 9 Nov 2026 | Charles Sigal | Independent Director | Open Market Acquisition | +1,600 | $152.25 | 4,375 |
| 8 Nov 2026 | Amy W. Schulman | Independent Chairperson | Open Market Acquisition | +1,910 | $156.82 | 25,121 |
| 1 Oct 2026 | Bryan Supran | Chief Legal Officer | Open Market Disposition | -1,758 | $226.88 | 2,584 |
| 1 Oct 2026 | Bryan Supran | Chief Legal Officer | Intent to Sell (Form 144) | -1,758 | $226.88 | – |
| 18 Sep 2026 | Yvonne Greenstreet | Chief Executive Officer | Other Acquisition | +107 | – | 62,470 |
| 31 May 2026 | David E. Pyott | Independent Director | Derivative Exercise and Sale | -3,830 | $302.65 | 28,811 |
| 31 May 2026 | Benjamin Cravatt | Director | Other Derivative Acquisition | +4,393 | $295.63 | 4,393 |
| 19 May 2026 | Peter Kellogg | Independent Director | Other Acquisition | +671 | – | 671 |
| 19 May 2026 | Peter Kellogg | Independent Director | Other Derivative Acquisition | +1,441 | $298.48 | 1,441 |
| 19 May 2026 | David E. Pyott | Independent Director | Other Acquisition | +671 | – | 671 |
| 19 May 2026 | David E. Pyott | Independent Director | Other Derivative Acquisition | +1,441 | $298.48 | 1,441 |
| 19 May 2026 | Charles Sigal | Independent Director | Other Acquisition | +671 | – | 671 |
| 19 May 2026 | Charles Sigal | Independent Director | Other Derivative Acquisition | +1,441 | $298.48 | 1,441 |
| 19 May 2026 | Margaret Hamburg | Independent Director | Other Acquisition | +671 | – | 671 |
| 19 May 2026 | Margaret Hamburg | Independent Director | Other Derivative Acquisition | +1,441 | $298.48 | 1,441 |
| 19 May 2026 | Amy W. Schulman | Independent Chairperson | Other Acquisition | +838 | – | 838 |
| 19 May 2026 | Amy W. Schulman | Independent Chairperson | Other Derivative Acquisition | +1,802 | $298.48 | 1,802 |
| 19 May 2026 | Dennis Ausiello | Member of the Scientific Advisory Board & Independent Director | Other Acquisition | +671 | – | 671 |
| 19 May 2026 | Dennis Ausiello | Member of the Scientific Advisory Board & Independent Director | Other Derivative Acquisition | +1,441 | $298.48 | 1,441 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 5,465,979 | 4.1% | 1.9 |
| 15 Oct 2026 | 6,568,786 | 4.9% | 5.1 |
| 30 Sep 2026 | 7,711,495 | 5.8% | 6.5 |
| 15 Sep 2026 | 7,194,097 | 5.4% | 4.1 |
| 31 Aug 2026 | 6,340,087 | 4.7% | 3.9 |
| 14 Aug 2026 | 4,770,978 | 3.6% | 2.4 |
No comments yet — be the first to weigh in on ALNY.
Sign in to join the discussion.